April 01, 2026

FDA Approves Lilly’s Foundayo Oral GLP-1 Pill

The newly approved therapy offers a noninjectable option that can be taken at any time of day without food or water restrictions.

Conexiant

March 31, 2026

Postzoster Neuralgia Linked to Tinnitus

Nationwide cohort analysis finds higher tinnitus incidence during long-term follow-up among patients with postzoster neuralgia, particularly older patients and certain comorbidities.

Conexiant

March 30, 2026

Top 10 States With the Most Favorable Tax Climate for Physicians

These 10 states differ in how they structure income, property, and sales taxes—factors that can influence overall tax exposure for physicians.

Conexiant

March 27, 2026

ACSM Revises Resistance Training Guidance

Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.

Conexiant

March 26, 2026

Ultrasound Models Estimate Whole-Body Muscle Mass

New equations incorporating cross-sectional area improve estimation accuracy.

Conexiant

March 23, 2026

Fibromyalgia Drugs Tested for Value

Investigators compare common fibromyalgia therapies.

Conexiant

March 19, 2026

Sleep Apnea Device Receives FDA Approval

Randomized trial data support the approval, with sustained improvements in apnea severity observed.

Conexiant

March 17, 2026

Side Effects: When the Obvious Call Is the Wrong One

Dialysis, nicotine, caffeine, and tattoos — four studies that quietly rearrange what good clinical instinct looks like.

Conexiant

March 17, 2026

Obesity Medications Get New Guidance

Panel outlines pharmacotherapy roles across obesity complications and long-term weight management.

Conexiant

March 13, 2026

Sleep Duration Signals Metabolic Change

Weekend sleep recovery shows mixed metabolic associations depending on weekday sleep duration.

Conexiant